公司新闻
更多>>公司公告
更多>>- 06/044d Pharma PLC--Asthma trial Part A enrolment and program update
- 02/154d Pharma PLC--Cancellation of admission to trading on AIM
- 02/024d Pharma PLC--Updated Results from Renal Cell Carcinoma Cohort
- 01/164d Pharma PLC--Result of Meeting
- 12/304d Pharma PLC--Update on Administration and Suspension of Trading
- 11/164d Pharma PLC--Blautix Phase II Clinical Trial Results Published
- 11/104d Pharma PLC--MRx0518 SITC 2022 poster presentations
- 10/054d Pharma PLC--MRx0518 poster presentations at SITC 2022
- 09/294d Pharma PLC--Update on Suspension of Trading on AIM
- 08/244d Pharma PLC--Publication of preclinical autism research
- 08/044d Pharma PLC--Publication of Joint Administrators' Proposals
- 07/014d Pharma PLC--Temporary Pause of Recruitment in Clinical Trials
- 06/284d Pharma PLC--4D Pharma receives Notice of Delisting from NASDAQ
- 06/284d Pharma PLC--Result of AGM